More On

Glaxo Said to Pay More Than $250 Million to Settle Avandia Death Lawsuits

GlaxoSmithKline Plc agreed to pay more than $250 million to resolve about 5,500 claims related to its Avandia diabetes drug and avoid the first trial over claims it kills users, two people familiar with the accords said.

Glaxo, the U.K.'s biggest drugmaker, agreed to settle the lawsuits claiming the drug causes heart attacks for an average of at least $46,000 each, said the people, who declined to be identified because they weren't authorized to speak publicly.

Join the Conversation

Advertisement. Closing in 15 seconds.